The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of adenoviral p53 (Ad-p53) tumor suppressor immune gene therapy on checkpoint inhibitor resistance and abscopal therapeutic efficacy.
 
Robert E. Sobol
Employment - Multivir
Leadership - Multivir
Stock and Other Ownership Interests - Multivir
Research Funding - Multivir
Patents, Royalties, Other Intellectual Property - Multivir
 
Sunil Chada
Employment - Multivir
Leadership - Multivir
Stock and Other Ownership Interests - Multivir
Consulting or Advisory Role - Multivir
Research Funding - Multivir
Patents, Royalties, Other Intellectual Property - Multivir
 
Dora Bocangel Wiederhold
Employment - Multivir
Stock and Other Ownership Interests - Multivir
Consulting or Advisory Role - Multivir
Research Funding - Multivir
Patents, Royalties, Other Intellectual Property - Multivir
 
Chae-Ok Yun
Employment - Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Multivir
Patents, Royalties, Other Intellectual Property - Genentech
 
Hyomin Ahn
Research Funding - Multivir
 
Eonju Oh
Research Funding - Multivir
 
Ravi Murthy
Consulting or Advisory Role - AstraZeneca
Research Funding - Multivir; Sirtex Medical
 
Vivek Subbiah
Research Funding - Novartis, GSK, Nanocarrier, NorthWest Biotherapeutics, Roche/Genentech, BergPharma, Bayer, Incyte, FujiFilm, Pharmamar, D3, Pfizer Amgen, Abbvie, Multivir, Bluprint Medicines.
Travel, Accommodations, Expenses - Novartis, Pharmamar, Fujifilm
 
Kerstin B. Menander
Employment - Multivir; Multivir (I)
Leadership - Multivir; Multivir
Stock and Other Ownership Interests - Multivir; Multivir (I)
Consulting or Advisory Role - Multivir; Multivir (I)
Research Funding - Multivir; Multivir (I)
Patents, Royalties, Other Intellectual Property - Multivir